Article

Prognostic value of preoperative inflammatory markers in patients with different molecular subgroups of WHO grade II and III diffuse gliomas

2019-12-17

Abstract excerpt

<h4>Background: </h4> To determine the prognostic implications of these immune indices in WHO Grade II & III gliomas and different molecular subgroups. <h4>Methods: </h4> Clinical data from 214 newly diagnosed WHO grade II and III diffuse glioma patients were studied retrospectively. Cut-off values were determined by X-tile software. IDH and TERT promotor mutations were detected by gene sequencing, and 1p19q codel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 80ba924b-c474-543f-a214-6257409f6059
DOI: 10.21203/rs.2.19038/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of preoperative inflammatory markers in patients with different molecular subgroups of WHO grade II and III diffuse gliomasDOI 10.21203/rs.2.19038/v1Read

Prognostic value of preoperative inflammatory markers in patients with different molecular subgroups of WHO grade II and III diffuse gliomasSemantic proximity Read

The Diagnostic Significance of Cellular Immune Inflammation Markers in Assessing Different Malignancy Grades GliomasSemantic proximity Read

Genomic Profiling of lower-grade gliomas subtype with distinct molecular and clinicopathologic characteristics via altered DNA-damage repair featuresSemantic proximity Read

Identification of molecular subtypes based on inflammatory response in lower-grade gliomaSemantic proximity Read

Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosisSemantic proximity Read

Inflammatory expression profiling defines the tumor microenvironment and immunity in lower-grade gliomasSemantic proximity Read

Systematic analysis of 4-gene prognostic signature in patients with diffuse gliomas based on gene expression profilesSemantic proximity Read

Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.Semantic proximity Read

Expression Profiling of IDH, p53, ATRX, and KI-67 Immunostains as Potential Grid for Molecular Subtyping of Adult Diffuse Gliomas from PakistanSemantic proximity Read

Prognostic Value of a Nomogram Model Based on Tumor Immune Markers and Clinical Factors for Adult Primary GliomasSemantic proximity Read

Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival.Semantic proximity Read